Worldwide: Healthcare

It aims to use technologies like artificial intelligence (AI) to "ensure timely and appropriate Medicare payment for select items and services."

On July 31, 2025, the Health Resources and Services Administration (HRSA) Office of Pharmacy Affairs (OPA) announced the availability of a voluntary 340B Rebate Model Pilot Program that will allow drug manufacturers to provide 340B-discounted drug prices using a rebate mechanism in limited cases starting January 1, 2026.

The surge in health and wellness devices—including wearables, beauty devices and more—comes a result of consumer interest in preventive health measures.

With the first half of 2025 in the rearview mirror, the government's continued focus on False Claims Act (FCA) enforcement shows no signs of slowing.

Dr. Keith Bellovich delivered a fast-paced and highly relevant overview of the federal policy and legislative environment impacting kidney care.

The President signed H.R. 1, the One Big Beautiful Bill Act (the "Act"), into law on July 4, 2025. In Section 71113, the Act restricts the flow of Federal Medicaid...

During a White House "Make Health Tech Great Again" event on July 30, President Trump announced the launch of a wide-ranging Health Technology Ecosystem initiative, a public-private partnership focused on the development...

Minnesota and Iowa have longstanding drug testing laws that place them among the more difficult states for employer compliance. This year, both states modified their laws in ways that require employers...

In spring 2025, the Food and Drug Administration (FDA) resolved and ended the GLP-1 medications shortage, subsequently releasing declaratory orders that neither outsourcing compounding pharmacies...